Other Commercial Matters Sample Clauses

Other Commercial Matters. Free storage of equipments is limited to maximum 2 weeks, after that it will be subjected to unit rates of USD50/M2/week * Liquidated Damages: Our proposal is NOT provided for LAD at this stage * Cancellation / Termination Costs Percentage of Cancellation Schedule No Total Contract Sum (week) 1 weeks from date of order 2 weeks from date of order 3 weeks from date of order 4 weeks from date of order 5 weeks from date of order
AutoNDA by SimpleDocs
Other Commercial Matters. Free storage of equipments is limited to maximum 2 weeks, after that it will be subjected to unit rates of USD /M2/week * Liquidated Damages: Our proposal is NOT provided for LAD at this stage * Cancellation / Termination Costs Percentage of Total Cancellation Schedule No Contract Sum (week) 1 weeks from date of order 2 weeks from date of order 3 weeks from date of order 4 weeks from date of order 5 weeks from date of order Anne Smith From: Debbie Wyatt Sent: Tuesday, 5 August 2008 1:21 PM To: Adam Dickens Cc: Subject: RE: MOPU-1003-L — Autoclave RE: WES CONFIDENTIAL QUOTATION : Importance: High Hi Adam We are currently completing Section 4 Form of Tender and will email as soon as complete. Best regards W.E. Smith Engineering Pty Ltd Debbie Wyatt Sales Office Co-ordinator Ph: 61 2 6650 8803 (Direct) Fax: 61 2 6658 3103 Email: Website: xxx.xxxxxx.xxx.xx From: Sent: Tuesday, 5 August 2008 11:52 To: Debbie Wyatt Cc: Subject: MOPU-1003-L — Autoclave RE: WES CONFIDENTIAL QUOTATION : Importance: High Hi Debbie, Thank you for your email. I acknowledge receipt of your email, with one attached file. I would like to ask if you could please send through W.E. Smith’s completed section 4 document? We require this document to accurately assess tender submissions. Kind regards, Adam Dickens From: Debbie Wyatt [mailto: ] Sent: Tuesday, 5 August 2008 11:30 AM To: Adam Dickens Cc: Subject: WES CONFIDENTIAL QUOTATION : MOPU-1003-L — Autoclave Importance: High WES REF: J0807701 (KNM Ref: K0807036) Hi Adam Please find attached our tender submission for your above referenced enquiry. Two (2) hard copies will follow via TNT courier con note nbr 601276048. If you have any queries please do not hesitate to contact us. Best regards W.E. Smith Engineering Pty Ltd Debbie Wyatt Sales Office Co-ordinator Ph: 61 2 6650 8803 (Direct) Fax: 61 2 6658 3103 Email: Website: xxx.xxxxxx.xxx.xx Anne Smith From: Debbie Wyatt Sent: Tuesday, 22 July 2008 9:55 AM To: Adam Dickens Cc: MOPU; Paul McFarlane; Roxane Fitzroy

Related to Other Commercial Matters

  • Financial Matters (a) The Borrower has heretofore furnished to the Lender copies of (i) the audited consolidated balance sheets of the Borrower and its Subsidiaries as of December 31, 1998, 1997, and 1996, and the related statements of income, stockholders' equity and cash flows for the fiscal years then ended, together with the opinion of KPMG Peat Marwick thereon or PricewaterhouseCoopers, and (ii) the unaudited consolidated balance sheet of the Borrower and its Subsidiaries as of June 30, 1999, and the related statements of income, stockholders' equity and cash flows for the nine-month period then ended. Except as set forth in Schedule 4.11(a) attached hereto, such financial statements have been prepared in accordance with Generally Accepted Accounting Principles (subject, with respect to the unaudited financial statements, to the absence of notes required by Generally Accepted Accounting Principles and to normal year-end audit adjustments) and present fairly the financial condition of the Borrower and its Subsidiaries on a consolidated basis as of the respective dates thereof and the consolidated results of operations of the Borrower and its Subsidiaries for the respective periods then ended. Except as fully reflected in the most recent financial statements referred to above and the notes thereto, there are no material liabilities or obligations with respect to the Borrower or any of its Subsidiaries of any nature whatsoever (whether absolute, contingent or otherwise and whether or not due).

  • General Matters The parties hereto agree that they will, in good faith and with their best efforts, cooperate with each other to carry out the transactions contemplated by this Agreement and to effect the purposes hereof.

  • Research Matters By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent’s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.

  • Non-Ministerial Matters (i) With respect to matters that in the reasonable judgment of the Administrator are non-ministerial, the Administrator shall not take any action unless within a reasonable time before the taking of such action, the Administrator shall have notified the Owner Trustee of the proposed action and the Owner Trustee shall not have withheld consent or provided an alternative direction. For the purpose of the preceding sentence, "non-ministerial matters" shall include, without limitation:

  • Legal Matters In the opinion of Xxxxxxxx Xx, Authorized Signatory of Prospect Administration, administrator for Prospect Capital Corporation, a Maryland corporation (the “Company”), the certificates evidencing the Notes (the “Note Certificates”) constitute the valid and binding obligations of the Company, entitled to the benefits of the Indenture and enforceable against the Company in accordance with their terms under the laws of the State of New York subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above. This opinion is given as of the date hereof and is limited to the law of the State of New York as in effect on the date hereof. In addition, this opinion is subject to the same assumptions and qualifications stated in the letter of Skadden, Arps, Slate, Xxxxxxx & Xxxx, LLP dated March 8, 2012, filed as Exhibit (l)(5) to the Company’s registration statement on Form N-2 (File No. 333-176637) and to the further assumptions that (i) the Note Certificates have been duly authorized by all requisite corporate action on the part of the Company and duly executed by the Company under Maryland law, and (ii) they were duly authenticated by the Trustee and issued and delivered by the Company against payment therefor in accordance with the terms of the Fifth Amended and Restated Selling Agent Agreement and the Indenture. Capitalized terms used in this paragraph without definition have the meanings ascribed to them in the accompanying prospectus supplement. Prospect Capital Corporation 00 Xxxx 00xx Xxxxxx, 00xx Xxxxx Xxx Xxxx, Xxx Xxxx 00000

  • Operational Matters Except as would not, individually or in the aggregate, be reasonably expected to result in a Company Material Adverse Effect:

  • FDA Matters (a) The Corporation has (i) complied in all material respects with all applicable laws, regulations and specifications with respect to the manufacture, design, sale, storing, labeling, testing, distribution, inspection, promotion and marketing of all of the Corporation’s products and product candidates and the operation of manufacturing facilities promulgated by the U.S. Food and Drug Administration (the “FDA”) or any corollary entity in any other jurisdiction and (ii) conducted, and in the case of any clinical trials conducted on its behalf, caused to be conducted, all of its clinical trials with reasonable care and in compliance in all material respects with all applicable laws and the stated protocols for such clinical trials.

  • Fiscal Matters 14 Section 4.11

  • Personnel Matters (a) Schedule 3.15(a) sets forth a correct and complete list of each director, officer, employee, independent contractor, consultant and agent of Company, including but not limited to, each employee on leave of absence or layoff status. No retired employee, director, of officer of Company is receiving benefits or scheduled to receive benefits in the future.

  • Loan Matters (i) All Loans held by the Company or any of its Subsidiaries were made in all material respects for good, valuable and adequate consideration in the ordinary course of the business, in accordance in all material respects with sound banking practices and, to the Knowledge of the Company, the Loans are not subject to any defenses, setoffs or counterclaims, including without limitation any such as are afforded by usury or truth in lending laws, except as may be provided by bankruptcy, insolvency or similar laws or by general principles of equity. The notes or other evidences of indebtedness evidencing such Loans and all forms of pledges, mortgages and other collateral documents and security agreements are, in all material respects, enforceable and valid.

Time is Money Join Law Insider Premium to draft better contracts faster.